Legislative record

S 488STATE · New YorkIn Committee

Enacts the manufacturer disclosure and transparency act

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Voted 5/12/2026

Roll-call record

How representatives voted

108 yea·29 nay·3 other

Docket history

Action history

  1. 1/28/2026REPORTED AND COMMITTED TO FINANCE
  2. 1/7/2026DIED IN ASSEMBLY
  3. 1/7/2026RETURNED TO SENATE
  4. 1/7/2026REFERRED TO CONSUMER PROTECTION
  5. 6/9/2025REPASSED SENATE
  6. 6/9/2025DELIVERED TO ASSEMBLY
  7. 6/9/2025REFERRED TO CONSUMER AFFAIRS AND PROTECTION
  8. 5/22/2025RECALLED FROM ASSEMBLY
  9. 5/22/2025RETURNED TO SENATE
  10. 5/22/2025VOTE RECONSIDERED - RESTORED TO THIRD READING